A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)

Clinical trial NCT00779883 · COMPLETED

Trial details

NCT number: NCT00779883
Sponsor: Memgen, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2006-06-01
Primary completion: 2008-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.